Quipt Home Medical Corp. (TSX:QIPT)
Canada · Delayed Price · Currency is CAD 4.840
+0.030 (0.62%)
Feb 11, 2026, 3:15 PM EST
Quipt Home Medical Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 264.97 | 245.36 | 245.92 | 211.68 | 127.64 | 94.39 | |
Revenue Growth (YoY) | 8.28% | -0.23% | 16.18% | 65.84% | 35.22% | 29.95% |
Cost of Revenue | 73.19 | 68.18 | 68.93 | 57.9 | 33.21 | 28.17 |
Gross Profit | 191.78 | 177.18 | 176.99 | 153.78 | 94.42 | 66.22 |
Selling, General & Admin | 136.63 | 125.46 | 122.54 | 103.22 | 65.2 | 44.66 |
Amortization of Goodwill & Intangibles | 12.97 | 12.49 | 12.07 | 10.33 | 2.59 | 1.57 |
Other Operating Expenses | - | - | - | - | -4.89 | - |
Operating Expenses | 195.25 | 181.41 | 175.58 | 149.73 | 88.85 | 67.39 |
Operating Income | -3.46 | -4.23 | 1.41 | 4.05 | 5.57 | -1.17 |
Interest Expense | -7.37 | -6.29 | -8.29 | -5.91 | -2.08 | -1.99 |
Interest & Investment Income | 0.37 | 0.47 | 0.79 | 0.37 | - | - |
Earnings From Equity Investments | -0.29 | -0.32 | -0.31 | -0.09 | - | - |
Currency Exchange Gain (Loss) | 0.56 | -0.37 | 0.04 | 0.11 | -0.14 | -0.17 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -2.11 |
EBT Excluding Unusual Items | -10.19 | -10.75 | -6.36 | -1.48 | 3.35 | -5.45 |
Merger & Restructuring Charges | -1.06 | -0.82 | -0.4 | -1.27 | -0.8 | -0.23 |
Gain (Loss) on Sale of Assets | 1.28 | 1.23 | 0.11 | 0.08 | -0.05 | 0.09 |
Legal Settlements | - | - | - | - | - | -0.15 |
Other Unusual Items | - | - | - | -0.03 | 0.43 | -3.59 |
Pretax Income | -9.97 | -10.34 | -6.65 | -2.7 | 2.94 | -9.33 |
Income Tax Expense | 0.24 | 0.24 | 0.11 | 0.09 | -1.9 | -3.16 |
Earnings From Continuing Operations | -10.21 | -10.58 | -6.76 | -2.78 | 4.84 | -6.17 |
Net Income to Company | -10.21 | -10.58 | -6.76 | -2.78 | 4.84 | -6.17 |
Minority Interest in Earnings | -0.46 | -0.12 | - | - | - | - |
Net Income | -10.67 | -10.7 | -6.76 | -2.78 | 4.84 | -6.17 |
Net Income to Common | -10.67 | -10.7 | -6.76 | -2.78 | 4.84 | -6.17 |
Shares Outstanding (Basic) | 43 | 43 | 43 | 39 | 34 | 30 |
Shares Outstanding (Diluted) | 43 | 43 | 43 | 39 | 36 | 30 |
Shares Change (YoY) | 1.57% | 1.86% | 10.09% | 6.35% | 19.27% | 33.96% |
EPS (Basic) | -0.25 | -0.25 | -0.16 | -0.07 | 0.14 | -0.20 |
EPS (Diluted) | -0.25 | -0.25 | -0.16 | -0.07 | 0.13 | -0.20 |
Free Cash Flow | 26.59 | 25.34 | 25.07 | 30.13 | 17.18 | 12.72 |
Free Cash Flow Per Share | 0.61 | 0.58 | 0.59 | 0.78 | 0.47 | 0.42 |
Gross Margin | 72.38% | 72.21% | 71.97% | 72.65% | 73.98% | 70.16% |
Operating Margin | -1.31% | -1.72% | 0.57% | 1.91% | 4.37% | -1.24% |
Profit Margin | -4.03% | -4.36% | -2.75% | -1.31% | 3.79% | -6.54% |
Free Cash Flow Margin | 10.03% | 10.33% | 10.19% | 14.23% | 13.46% | 13.47% |
EBITDA | 43.58 | 41.25 | 45.99 | 40.15 | 24.4 | 13.84 |
EBITDA Margin | 16.45% | 16.81% | 18.70% | 18.96% | 19.11% | 14.66% |
D&A For EBITDA | 47.04 | 45.48 | 44.58 | 36.1 | 18.83 | 15.01 |
EBIT | -3.46 | -4.23 | 1.41 | 4.05 | 5.57 | -1.17 |
EBIT Margin | -1.31% | -1.72% | 0.57% | 1.91% | 4.37% | -1.24% |
Revenue as Reported | 264.97 | 245.36 | 245.92 | 211.68 | 139.86 | 102.35 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.